Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $28.00 Average Target Price from Brokerages

Crescent Biopharma, Inc. (NASDAQ: CBIO - Get Free Report) has been given an average rating of "Buy" by the nine brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have assigned a buy recommendation and three have assigned a strong buy recommendation to the